Background and objective.

There are multiple perioperative cares to prevent complications, from the proper selection of the patient to the use of medications to reduce blood loss during the transoperative period. The current trend is to prevent rather than treat, and tranexamic acid has been tested in multiple surgeries for purposes of saving blood, reducing ecchymosis and inflammation, and as a depigmentation agent.

We carried out this research with the objective of showing the usefulness of tranexamic acid and increasing its use in Plastic Surgery to reduce intraoperative blood loss and as a treatment for hyperpigmentation, in order to guarantee greater patient safety.

Methods.

Literature review in Pubmed, Elsevier, Google Scholar, Research and Scielo; articles in English and Spanish using three search strategies by combining descriptors with boolean operators, limiting the "AND" for different terms and the "OR" for homologues, between 1968 and 2022.

Results.

Through the knowledge of the pharmacokinetics of tranexamic acid, we verified that, in addition to its usefulness in the prevention of bleeding, through the inhibition of complement and melanin synthesis it has also been shown to be useful as a depigmenting agent in hyperchromia.

Conclusions.

This study contributes to better understand the benefits of tranexamic acid to prevent bleeding in surgery and as a skin depigmentation agent. We believe that this last aspect opens a door for the study of its application in the treatment of hyperpigmentation produced in iatrogenic allogeneic disease, a utility that would be added to those already known.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )